Synthesis and Biological Evaluation of Novel 1-Deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-β-d-ribofuranuronamide Derivatives as Useful Templates for the Development of A2B Adenosine Receptor Agonists-Reference-Cited by-同舟云学术

Synthesis and Biological Evaluation of Novel 1-Deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-β-d-ribofuranuronamide Derivatives as Useful Templates for the Development of A2B Adenosine Receptor Agonists

Published:2006-12-22 Issue:2 Volume:50 Page:374-380
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baraldi Pier Giovanni¹,Preti Delia¹,Tabrizi Mojgan Aghazadeh¹,Fruttarolo Francesca¹,Romagnoli Romeo¹,Carrion Maria Dora¹,Cara Luisa Carlota Lopez¹,Moorman Allan R.¹,Varani Katia¹,Borea Pier Andrea¹

Affiliation:

1. Dipartimento di Scienze Farmaceutiche and Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università di Ferrara, 44100 Ferrara Italy, King Pharmaceutical Research and Development, Inc., 4000 CentreGreen Way, Suite 300, Cary, North Carolina 27513

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm061170a

Reference43 articles.

1. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development;Molecular Diversity;2021-06-27

2. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives;Current Pharmaceutical Design;2019-10-03

3. Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives;Drug Discovery Today;2019-09

4. Tritium-labeled agonists as tools for studying adenosine A2B receptors;Purinergic Signalling;2018-05-11

5. The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor;European Journal of Medicinal Chemistry;2018-04